A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
about
Nedaplatin: a cisplatin derivative in cancer chemotherapyPaclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinomaA Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma.A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin TherapyPhase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinomaPhase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.Primary squamous cell carcinoma of the esophagus initially presenting as a large retroperitoneal mass: A case diagnosed as cancer of unknown primary site.Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma.Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy.The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
P2860
Q24623561-78F9D867-3E27-4BB5-B76A-55256ABC6DFAQ33394158-921C7FD7-66D4-43CE-98CA-24D31D6C3B87Q33405628-C9E324A2-2E52-47E8-8EE7-C5333054D251Q33410922-E4A4DF11-6593-46B6-96F2-7A619FCC931EQ33433296-330F51B3-A33B-485F-B9D9-26240869EAF4Q33607983-A3A6E705-643E-46AF-A82D-19B2D29A1045Q34010159-34CD7C37-DA8D-4082-B947-3B6E42EDB4F0Q36891363-F5E2458F-C7E5-491D-9B74-9D0EA073743EQ37142445-0B5584B2-E799-46BC-8DAF-938091DAC2D4Q37378328-A1719974-D281-4287-9F2E-77EBB48BBE9CQ37382552-14AE2762-516B-4063-8FA2-864FBA908500Q37560914-E44ACBAD-C714-40A5-BEDD-AC9F0980CC14Q47094941-B526629F-8392-4FF1-8320-32AF7281E10EQ53127618-729B95A9-6FF7-4AD2-865A-0CA587DA7DCEQ53148675-DAD48230-EE6D-4884-BFC2-A0CE517F29B0
P2860
A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@ast
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@en
type
label
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@ast
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@en
prefLabel
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@ast
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@en
P2093
P356
P1476
A phase II study of paclitaxel ...... th advanced esophageal cancer.
@en
P2093
Guying Lou
Jinsong Jiang
Shunguang Zhao
Weiguo Cao
Yening Jin
P304
P356
10.1093/JJCO/HYP058
P577
2009-06-09T00:00:00Z